Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 8/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.39 |
| ▸ | ALOX5AP | P20292 | 2/20 | 0.38 |
| ▸ | FEN1 | P39748 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | PTGES2 | Q9H7Z7 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6999477 | 0.90 | ALOX5AP (0.38) | KIF11PTGS2PTGS1ALOX5APFEN1 | |
| SCHEMBL6994669 | 0.89 | PTGES2 (0.39) | PTGS2PTGS1ALOX5APFEN1PTGES2 | |
| SCHEMBL6999336 | 0.89 | PTGS2 (0.50) | PTGS2PTGS1 | |
| SCHEMBL6997334 | 0.87 | PTGS2 (0.41) | PTGS2PTGS1ALOX5APFEN1 | |
| SCHEMBL6998318 | 0.87 | PTGS2 (0.41) | PTGS2PTGS1ALOX5APFEN1 | |
| SCHEMBL7003332 | 0.86 | PTGS2 (0.41) | PTGS2PTGS1 | |
| SCHEMBL3223651 | 0.86 | PTGS2 (0.42) | PTGS2PTGS1 | |
| SCHEMBL3228803 | 0.85 | PTGS2 (0.44) | PTGS2PTGS1 | |
| SCHEMBL7002176 | 0.83 | CA1 (0.40) | PTGS2PTGS1 | |
| SCHEMBL6999446 | 0.83 | PTGS2 (0.37) | KIF11PTGS2PTGS1ALOX5APFEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1109799-B1 | 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS | PACIFIC CORP (KR) | 2003-12-17 | — | — | EP | claimed |
| US-6492416-B1 | TREATING INFLAMMATION AND ASSOCIATED DISORDERS | PACIFIC CORPORATION (KR) | 2002-12-10 | — | — | US | claimed |
| EP-1109799-B1 | 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS | PACIFIC CORP (KR) | 2003-12-17 | — | — | EP | disclosed |
| US-6492416-B1 | TREATING INFLAMMATION AND ASSOCIATED DISORDERS | PACIFIC CORPORATION (KR) | 2002-12-10 | — | — | US | disclosed |